4//SEC Filing
Shah Nikita 4
Accession 0001738061-25-000004
CIK 0001723128other
Filed
Aug 24, 8:00 PM ET
Accepted
Aug 25, 4:27 PM ET
Size
6.9 KB
Accession
0001738061-25-000004
Insider Transaction Report
Form 4
Shah Nikita
Executive Vice President
Transactions
- Sale
Class A Common Stock
2025-08-25$9.50/sh−6,340$60,230→ 146,403 total - Sale
Class A Common Stock
2025-08-22$9.66/sh−114,492$1,105,993→ 152,743 total
Footnotes (2)
- [F1]The price included in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.60 to $9.75 per share, inclusive. The Reporting Person undertakes to provide to Amneal Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F2]The price included in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.50 to $9.51 per share, inclusive. The Reporting Person undertakes to provide to Amneal Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Documents
Issuer
Amneal Pharmaceuticals, Inc.
CIK 0001723128
Entity typeother
Related Parties
1- filerCIK 0001738061
Filing Metadata
- Form type
- 4
- Filed
- Aug 24, 8:00 PM ET
- Accepted
- Aug 25, 4:27 PM ET
- Size
- 6.9 KB